These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [L-dopa and dopamine loading test]. Azuma K; Irahara M; Aono T Nihon Rinsho; 1997 Apr; 55 Suppl 2():252-5. PubMed ID: 9172519 [No Abstract] [Full Text] [Related]
3. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response. Bansal S; Lee LA; Woolf PD J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816 [No Abstract] [Full Text] [Related]
4. Cimetidine and L-dopa in the control of prolactin secretion in man. Pontiroli AE; Pellicciotta G; Alberetto M; De Pasqua A; Girardi AM; Pozza G Horm Metab Res; 1979 Mar; 11(3):257-8. PubMed ID: 447211 [No Abstract] [Full Text] [Related]
5. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
6. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients]. Vasil'ev VN Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421 [TBL] [Abstract][Full Text] [Related]
7. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels. Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[beta-11C]DOPA. Ito H; Ota M; Ikoma Y; Seki C; Yasuno F; Takano A; Maeda J; Nakao R; Suzuki K; Suhara T Nucl Med Commun; 2006 Sep; 27(9):723-31. PubMed ID: 16894327 [TBL] [Abstract][Full Text] [Related]
9. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864 [TBL] [Abstract][Full Text] [Related]
10. [The effects of l-dopa administration on the prolactin levels in short-stature subjects]. Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496 [TBL] [Abstract][Full Text] [Related]
11. [The L-dopa test in Parkinson's disease]. Esteguy M; Bonnet AM; Kefalos J; Lhermitte F; Agid Y Rev Neurol (Paris); 1985; 141(5):413-5. PubMed ID: 4048732 [TBL] [Abstract][Full Text] [Related]
12. [Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test]. Cueto Ladrón de Guevara J; García Puche JL; Pedraza V Rev Esp Oncol; 1985; 32(3):459-70. PubMed ID: 3870537 [TBL] [Abstract][Full Text] [Related]
13. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration. Fujita M; Shimizu T Bull Osaka Med Sch; 1986 Oct; 32(2):73-84. PubMed ID: 3122863 [No Abstract] [Full Text] [Related]
15. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration. Delitala G; Masala A Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170 [TBL] [Abstract][Full Text] [Related]
16. [Changes induced with L-dopa in the serum levels of prolactin and somatotropin in the diagnosis of amenorrhea-galactorrhea]. Campagnoli C; Fessia L; Gilli V; Pagliardini S; Peris C; Richetta R; Rustichelli S Minerva Ginecol; 1978 Mar; 30(3):135-8. PubMed ID: 566402 [No Abstract] [Full Text] [Related]
17. Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis. Delitala G; Masala A; Alagna S; Devilla L Biomedicine; 1976 Jul; 25(5):173-6. PubMed ID: 1000028 [TBL] [Abstract][Full Text] [Related]
18. Plasma testosterone during bicycle ergometer exercise without and after L-dopa pretreatment. Jezová-Repceková D; Vigas M; Mikulaj L; Jurcovicová J Endocrinol Exp; 1982 Mar; 16(1):3-8. PubMed ID: 6978249 [TBL] [Abstract][Full Text] [Related]
19. Proceedings: The importance of intracerebral decarboxylation of L-DOPA in the suppression of prolactin secretion. Franks S; Lawton NF; Marshall NJ J Physiol; 1975 Nov; 252(2):52P-54P. PubMed ID: 1206543 [No Abstract] [Full Text] [Related]
20. [The L-DOPA test in patients with obsessive fear neurosis]. Vasil'ev VN; Chugunov VS; Derbeneva LM; Eremeev MS Vopr Med Khim; 1988; 34(1):115-20. PubMed ID: 3369120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]